Teva Pharmaceutical Industries Ltd, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CLASCOTERONE, with a corresponding US DMF Number 39514.
Remarkably, this DMF maintains an Active status since its submission on February 28, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 20, 2024, and payment made on February 08, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II